Senti Bio Presents New Preclinical Data on Cancer-Killing Allogeneic CAR-NK Cells at AACR Annual Meeting
– Preclinical data demonstrate the use of gene circuits to improve the therapeutic potential of…
News
Editas Medicine Reports Engineered iNK Cell Preclinical Data at American Association for Cancer Research Annual Meeting
Preclinical data demonstrate that edited iNK cells result in increased persistence, enhanced anti-tumor activity and…
Tempest Presents Promising Preclinical Data on Two Oncology Programs at the 2022 AACR Annual Meeting
Anti-tumor data from systemic novel TREX1 inhibitors designed to activate the STING pathway selectively in…
Rubius Therapeutics Reports Updated Clinical Data at AACR from the Ongoing Monotherapy Phase 1 Arm of the Phase 1/2 Clinical Trial of RTX-240 in Advanced Solid Tumors Demonstrating Single-Agent Activity and Favorable Tolerability
Best Responses Include Partial Responses in Certain Patients with Non-Small Cell Lung Cancer, Metastatic Anal…
Anaveon presents compelling data from the Phase I/II study of ANV419 during the AACR Annual Meeting 2022
– ANV419 is very well-tolerated and demonstrates exceptional safety with strong pharmacodynamic effects and excellent…
Nykode Therapeutics announces presentation of preclinical data from its second generation Vaccibody vaccine technology at 2022 American Association for Cancer Research (AACR) Annual Meeting
OSLO, Norway, April 08, 2022 (GLOBE NEWSWIRE) — Nykode Therapeutics AS (Euronext Growth (Oslo): NYKD),…
Codiak’s exoASO™-C/EBPβ Demonstrates Significant Systemic Anti-Tumor Activity via Targeting Immune-Suppressive Myeloid Cells
– New preclinical data presented at AACR Annual Meeting 2022 – – Intravenous exosome candidate…
Monte Rosa Therapeutics Presents Preclinical Data Highlighting Potential of GSPT1-directed Molecular Glue Degrader MRT-2359 to Target Myc-driven Cancers at AACR Annual Meeting 2022
– Data Highlight Essential Role of GSPT1 in Sustaining Myc-induced Translational Addiction in Solid Tumors…
Zentalis Pharmaceuticals Announces Positive Initial Clinical Data on ZN-c3, its Wee1 Inhibitor, in Patients with Advanced Ovarian Cancer at AACR
ZN-c3 in combination with chemotherapy demonstrated strong anti-tumor activity in a heavily pretreated population, with…
C4 Therapeutics Presents Clinical Data from Cohort A of the Ongoing Phase 1/2 Clinical Trial of CFT7455, a Novel IKZF1/3 Degrader
– Single Agent CFT7455 Induces Deep and Durable Degradation of IKZF1/3 and Meaningful Decreases in…
Theratechnologies Presents New In Vivo TH1902 Preclinical Data Demonstrating Tumor Growth Inhibition of Human Cancer Stem-Like Cells (CD133+) in Both Triple-Negative Breast and Ovarian Cancers AACR Annual Meeting 2022
Two Additional Preclinical Proof-of-concept Posters in Ovarian and Metastatic Lung Cancer Models Also Presented at…
Biomea Fusion Reports Preclinical Data on BMF-219 and Trial in Progress Presentations at AACR 2022 Annual Meeting
Covalent menin inhibitor BMF-219 showed strong cytotoxic activity as a single agent at similar concentrations across…
Werewolf Therapeutics Presents Promising Preclinical Data on its Two Lead INDUKINE™ Molecules at AACR 2022 Annual Meeting
WTX-124 demonstrated high tumor selectivity and generated significant anti-tumor activity in a CD8+ T cell-dependent…
Ultimovacs Presents TET Platform Pre-Clinical Data at AACR 2022 Supporting Clinical Development
TET platform shows efficient T cell priming and beneficial safety profile Data supported clinical transition…
ImCheck Provides Updated ICT01 and Pembrolizumab Combination Data from the Phase I/IIa EVICTION Trial at AACR Annual Meeting 2022
ImCheck Provides Updated ICT01 and Pembrolizumab Combination Datafrom the Phase I/IIa EVICTION Trial at AACR…
Introducing Bitcoin City – The First Crypto City in Metaverse
Riga, Latvia–(Newsfile Corp. – April 8, 2022) – The Bitcoin City project is the metaverse’s…
KBRA Releases Solar Loan Index for March 2022
NEW YORK–(BUSINESS WIRE)–#KBRA–KBRA releases its solar loan index publication, providing monthly credit trends of securitized…
KBRA Releases RMBS Credit Indices (KCI) for March 2022
NEW YORK–(BUSINESS WIRE)–#KBRA–KBRA releases its RMBS Credit Indices (KCI) for March 2022. The indices track…
Kim & Serritella LLP and Barton LLP Announce a Securities Class Action Against Uniswap and Other Defendants Regarding the Unregistered Offer and Sale of Digital Tokens, and Lead Plaintiff Deadline
NEW YORK–(BUSINESS WIRE)–Kim & Serritella LLP and Barton LLP announce that a securities class action,…
Transgene to Present New Positive Preliminary Phase I Clinical Data at AACR 2022, Reinforcing the Potential of TG4050
Transgene will discuss new immunogenicity and clinical data generated with TG4050 that reinforce the strong…